(ad)

CRISPR QC pioneers streamlined and automated CRISPR quality control tools to accelerate research while improving accuracy and performance.

Creating the common language of genome editing

We are at the beginning of a genome editing revolution, and one of the significant challenges is the need for a common language. For the last two years, The National Institute of Standards and Technology (NIST) has developed the first lexicon for genome editing. The new lexicon will help ensure that the terms and definitions used in the field are consistent globally, eliminating ambiguity within the different scientific communities. Read our interview with Samantha Maragh, leader of NIST's genome editing program.

NB If you missed our 2019 interview with Samantha: Setting standards in the CRISPR genome editing revolution.

Pick of the Month

Dr Matthew Porteus, Stanford University, spoke to us on the CRISPR clinical trials to cure Sickle Cell Disease patients. Dr Matthew Porteus is a co-founder of Graphite Bio and a scientific founder of CRISPR Therapeutics. He gave us his perspective on both CRISPR therapies - Graphite Bio directly addressing the disease mutation and CRISPR Therapeutics taking a clever workaround. Please read it here: There Are Now Two Pushes to Treat Sickle Cell Disease With CRISPR.

Career CRISPR Medicine

• Postdoctoral Research Fellow | Massachusetts General Hospital and Harvard Medical School

• Freelancer | CRISPR Medicine News - Any place

Thank you for now - more great reads are on the way!

And if you have questions or suggestions, you can reach out to us directly at editor@crisprmedicinenews.com. We love hearing from readers!

Happy Reading!

Rasmus

p.s. You can follow CRISPR Medicine News on Twitter and LinkedIn. If someone forwarded this email to you, you can sign up for our newsletter yourself here.